SCHEMBL17653169

SCHEMBL17653169

CC(C)CC(CNC(=O)O)c1ncc2cc(CCBr)ccc2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 4/20 0.35
HCAR2 Q8TDS4 1/20 0.34
P2RX7 Q99572 3/20 0.34
AAK1 Q2M2I8 1/20 0.34
GRIN2D O15399 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
RAF1 P04049 3/20 0.32
CES2 O00748 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GCG P01275 2/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
S1PR1 P21453 1/20 0.30
S1PR3 Q99500 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653167 0.83 P2RX7 (0.39) P2RX7AAK1MEN1KMT2ASMN1; SMN2
SCHEMBL17653291 0.68 AAK1 (0.42) AAK1SMN1; SMN2KDM4ECYP2D6CYP2C19
SCHEMBL27629973 0.65 P4HTM (0.43) GRIN2DGRIN2AGRIN2BGRIN2CRAF1
SCHEMBL17493735 0.64 AAK1 (0.56) AAK1S1PR1
SCHEMBL27787814 0.63 CYP1A2 (0.53) HCAR2KDM4ENPC1RAB9A
SCHEMBL20509436 0.60 HPGD (0.43) CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL28776260 0.60 GRIN2D (0.39) ABL1GRIN2DGRIN2AGRIN2BGRIN2C
SCHEMBL27314267 0.59 EGFR (0.51)
Acetic Acid SCHEMBL27771808 0.59 CYP1A2 (0.58) HCAR2SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL22672456 0.59 TDP1 (0.46) HCAR2GRIN2DGRIN2AGRIN2BGRIN2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed